Exact Mass: 801.6611051999998

PC(15:0/22:1(13Z))

C45H88NO8P (801.6247218)

PC(15:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of erucic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of erucic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(20:0/P-18:0)

C46H92NO7P (801.6611051999998)

PC(20:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/P-18:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(20:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/P-18:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(22:0/P-16:0)

C46H92NO7P (801.6611051999998)

PC(22:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(22:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(22:1(13Z)/15:0)

C45H88NO8P (801.6247218)

PC(22:1(13Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/15:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(16:0/24:1(15Z))

C45H88NO8P (801.6247218)

PE(16:0/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(16:1(9Z)/24:0)

C45H88NO8P (801.6247218)

PE(16:1(9Z)/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/24:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:1(9Z)/24:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:1(9Z)/24:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one tetracosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:0/22:1(13Z))

C45H88NO8P (801.6247218)

PE(18:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:1(11Z)/22:0)

C45H88NO8P (801.6247218)

PE(18:1(11Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/22:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of behenic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:1(9Z)/22:0)

C45H88NO8P (801.6247218)

PE(18:1(9Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:0/20:1(11Z))

C45H88NO8P (801.6247218)

PE(20:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/20:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:1(11Z)/20:0)

C45H88NO8P (801.6247218)

PE(20:1(11Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/20:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(22:0/18:1(11Z))

C45H88NO8P (801.6247218)

PE(22:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(22:0/18:1(9Z))

C45H88NO8P (801.6247218)

PE(22:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of oleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of oleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:1(13Z)/18:0)

C45H88NO8P (801.6247218)

PE(22:1(13Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/18:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of stearic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:0/16:1(9Z))

C45H88NO8P (801.6247218)

PE(24:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/16:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:1(15Z)/16:0)

C45H88NO8P (801.6247218)

PE(24:1(15Z)/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/16:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PC(P-16:0/22:0)

C46H92NO7P (801.6611051999998)

PC(P-16:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/22:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of behenic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/22:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of behenic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:0/20:0)

C46H92NO7P (801.6611051999998)

PC(P-18:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/20:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/20:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(O-16:1(9Z)/22:0)

C46H92NO7P (801.6611051999998)

PC(O-16:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:1(9Z)/22:0), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-16:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/22:0), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(O-18:1(9Z)/20:0)

C46H92NO7P (801.6611051999998)

PC(O-18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/20:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/20:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of arachidic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

Culinariside

C45H87NO10 (801.6329642)

Culinariside is found in pulses. Culinariside is a constituent of the seeds of Lens culinaris (lentil) Constituent of the seeds of Lens culinaris (lentil). Culinariside is found in pulses.

PE-NMe(15:0/24:1(15Z))

C45H88NO8P (801.6247218)

PE-NMe(15:0/24:1(15Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(24:1(15Z)/15:0)

C45H88NO8P (801.6247218)

PE-NMe(24:1(15Z)/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:1(15Z)/15:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(14:0/24:1(15Z))

C45H88NO8P (801.6247218)

PE-NMe2(14:0/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:0/24:1(15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(14:1(9Z)/24:0)

C45H88NO8P (801.6247218)

PE-NMe2(14:1(9Z)/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:1(9Z)/24:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(16:0/22:1(13Z))

C45H88NO8P (801.6247218)

PE-NMe2(16:0/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(16:1(9Z)/22:0)

C45H88NO8P (801.6247218)

PE-NMe2(16:1(9Z)/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:1(9Z)/22:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:0/20:1(11Z))

C45H88NO8P (801.6247218)

PE-NMe2(18:0/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:1(11Z)/20:0)

C45H88NO8P (801.6247218)

PE-NMe2(18:1(11Z)/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/20:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:1(9Z)/20:0)

C45H88NO8P (801.6247218)

PE-NMe2(18:1(9Z)/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/20:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:0/18:1(11Z))

C45H88NO8P (801.6247218)

PE-NMe2(20:0/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:0/18:1(9Z))

C45H88NO8P (801.6247218)

PE-NMe2(20:0/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:1(11Z)/18:0)

C45H88NO8P (801.6247218)

PE-NMe2(20:1(11Z)/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:0/16:1(9Z))

C45H88NO8P (801.6247218)

PE-NMe2(22:0/16:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/16:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/16:0)

C45H88NO8P (801.6247218)

PE-NMe2(22:1(13Z)/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:0/14:1(9Z))

C45H88NO8P (801.6247218)

PE-NMe2(24:0/14:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:0/14:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:1(15Z)/14:0)

C45H88NO8P (801.6247218)

PE-NMe2(24:1(15Z)/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/14:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

JCer-4

C46H91NO9 (801.6693476)

Phosphatidylcholine 19:0-18:1

C45H88NO8P (801.6247218)

Phosphatidylethanolamine 18:0-22:1

C45H88NO8P (801.6247218)

Phosphatidylethanolamine 22:0-18:1

C45H88NO8P (801.6247218)

PC(O-18:0/20:1)

C46H92NO7P (801.6611051999998)

PE(22:1/18:0)[U]

C45H88NO8P (801.6247218)

PE(18:0/22:1)

C45H88NO8P (801.6247218)

PE(20:0/20:1)

C45H88NO8P (801.6247218)

PE(22:0/18:1)

C45H88NO8P (801.6247218)

PE(20:1/20:0)

C45H88NO8P (801.6247218)

PE(18:1/22:0)

C45H88NO8P (801.6247218)

PE(18:1/22:0)[U]

C45H88NO8P (801.6247218)

Lecithin

C45H88NO8P (801.6247218)

Lecithin

C46H92NO7P (801.6611051999998)

PE(40:1)

C45H88NO8P (801.6247218)

PC(15:0/22:1(11Z))

C45H88NO8P (801.6247218)

PC(15:1(9Z)/22:0)

C45H88NO8P (801.6247218)

PC(16:1(9Z)/21:0)

C45H88NO8P (801.6247218)

PC(17:0/20:1(11Z))

C45H88NO8P (801.6247218)

PC(17:1(9Z)/20:0)

C45H88NO8P (801.6247218)

PC(18:0/19:1(9Z))

C45H88NO8P (801.6247218)

PC(18:1(9Z)/19:0)

C45H88NO8P (801.6247218)

PC(O-16:0/22:1(11Z))

C46H92NO7P (801.6611051999998)

PC(O-18:0/20:1(11Z))

C46H92NO7P (801.6611051999998)

PC(O-20:0/18:1(9Z))

C46H92NO7P (801.6611051999998)

PC(P-20:0/18:0)

C46H92NO7P (801.6611051999998)

PE(P-20:0/21:0)

C46H92NO7P (801.6611051999998)

Culinariside

C45H87NO10 (801.6329642)

PC O-38:1

C46H92NO7P (801.6611051999998)

PE O-41:1

C46H92NO7P (801.6611051999998)

1-octadecyl-2-[(9Z)-eicosenoyl]-sn-glycero-3-phosphocholine

C46H92NO7P (801.6611051999998)

A phosphatidylcholine O-38:1 in which the alkyl and acyl groups at positions 1 and 2 are octadecyl and (9Z)-eicosenoyl respectively.

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

N-[2-[[[[(2S,3R)-2-(Tricosanoylamino)-3-hydroxy-4-octadecenyl]oxy]hydroxyphosphinyl]oxy]ethyl]trimethylaminium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-3-hydroxydocos-13-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C45H90N2O7P+ (801.6485299999999)

alpha-Glucuronosylceramide

C45H87NO10 (801.6329642)

N-tricosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

C46H91NO9 (801.6693476)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentacosanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-(tricosanoylamino)octadec-5-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-15-methyl-2-(tetracosanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-14-methyl-2-(tetracosanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

HexCer 18:0;3O/21:1;(2OH)

C45H87NO10 (801.6329642)

NAGly 26:7/24:2

C52H83NO5 (801.6270907999999)

NAGly 24:5/26:4

C52H83NO5 (801.6270907999999)

NAGly 26:5/24:4

C52H83NO5 (801.6270907999999)

[3-decoxy-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

HexCer 19:0;2O/21:0;O

C46H91NO9 (801.6693476)

HexCer 20:0;2O/20:0;O

C46H91NO9 (801.6693476)

HexCer 21:0;2O/19:0;O

C46H91NO9 (801.6693476)

HexCer 17:0;2O/23:0;O

C46H91NO9 (801.6693476)

HexCer 18:0;2O/22:0;O

C46H91NO9 (801.6693476)

HexCer 22:0;2O/18:0;O

C46H91NO9 (801.6693476)

HexCer 16:0;2O/24:0;O

C46H91NO9 (801.6693476)

HexCer 9:0;3O/30:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 8:0;3O/31:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 13:1;3O/26:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 12:0;3O/27:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 11:0;3O/28:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 10:0;3O/29:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 13:0;3O/26:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 12:1;3O/27:0;(2OH)

C45H87NO10 (801.6329642)

3-Hydroxy-2-(2-hydroxypentacosanoylamino)docosane-1-sulfonic acid

C47H95NO6S (801.687973)

3-Hydroxy-2-(2-hydroxyhexacosanoylamino)henicosane-1-sulfonic acid

C47H95NO6S (801.687973)

3-Hydroxy-2-(2-hydroxytricosanoylamino)tetracosane-1-sulfonic acid

C47H95NO6S (801.687973)

3-Hydroxy-2-(2-hydroxytetracosanoylamino)tricosane-1-sulfonic acid

C47H95NO6S (801.687973)

3-Hydroxy-2-(2-hydroxydocosanoylamino)pentacosane-1-sulfonic acid

C47H95NO6S (801.687973)

3-Hydroxy-2-(2-hydroxyhenicosanoylamino)hexacosane-1-sulfonic acid

C47H95NO6S (801.687973)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] pentadecanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-tetracos-13-enoate

C46H92NO7P (801.6611051999998)

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexacosoxypropan-2-yl] (Z)-pentadec-9-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octacosoxypropan-2-yl] (Z)-tridec-9-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] nonadecanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentacosoxypropan-2-yl] (Z)-hexadec-9-enoate

C46H92NO7P (801.6611051999998)

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytricosane-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (Z)-henicos-11-enoate

C46H92NO7P (801.6611051999998)

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] tetracosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (Z)-docos-13-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] octacosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] docosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] (Z)-heptadec-9-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-octacos-17-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] henicosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptacosoxypropan-2-yl] (Z)-tetradec-9-enoate

C46H92NO7P (801.6611051999998)

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentacos-4-ene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] icosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (Z)-octadec-9-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] tridecanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] heptadecanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] hexacosanoate

C46H92NO7P (801.6611051999998)

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-hexacos-15-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (Z)-icos-11-enoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (Z)-nonadec-9-enoate

C46H92NO7P (801.6611051999998)

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

C49H87NO5S (801.6304611999999)

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]pentacosane-1-sulfonic acid

C49H87NO5S (801.6304611999999)

[2-dodecanoyloxy-3-[(Z)-hexacos-15-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-dodecoxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-[(Z)-henicos-11-enoxy]-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-[(Z)-tetracos-13-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-henicosanoyloxy-3-[(Z)-heptadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-icosoxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-decanoyloxy-3-[(Z)-octacos-17-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-pentacosoxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-[(Z)-pentadec-9-enoxy]-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-docosoxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-tetracosoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-pentacosanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-[(Z)-icos-11-enoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tricosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-[(Z)-nonadec-9-enoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-[(Z)-docos-13-enoxy]-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-nonadecanoyloxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[3-henicosoxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

2-[4-[3-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/18:4;(3OH)(FA 20:6)

C52H83NO5 (801.6270907999999)

Cer 15:0;2O/21:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/20:5;(3OH)(FA 18:5)

C52H83NO5 (801.6270907999999)

Cer 15:0;2O/16:5;(3OH)(FA 21:5)

C52H83NO5 (801.6270907999999)

Cer 16:0;2O/20:6;(3OH)(FA 16:4)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/18:5;(3OH)(FA 20:5)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/16:4;(3OH)(FA 22:6)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/22:6;(3OH)(FA 16:4)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/19:5;(3OH)(FA 19:5)

C52H83NO5 (801.6270907999999)

Cer 16:0;2O/16:4;(3OH)(FA 20:6)

C52H83NO5 (801.6270907999999)

Cer 16:0;2O/18:5;(3OH)(FA 18:5)

C52H83NO5 (801.6270907999999)

Cer 16:0;2O/16:5;(3OH)(FA 20:5)

C52H83NO5 (801.6270907999999)

Cer 15:0;2O/19:5;(3OH)(FA 18:5)

C52H83NO5 (801.6270907999999)

Cer 20:0;2O/16:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/16:5;(3OH)(FA 22:5)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/22:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 16:0;2O/20:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 14:0;2O/20:6;(3OH)(FA 18:4)

C52H83NO5 (801.6270907999999)

Cer 18:0;2O/16:5;(3OH)(FA 18:5)

C52H83NO5 (801.6270907999999)

Cer 17:0;2O/19:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 18:0;2O/18:5;(3OH)(FA 16:5)

C52H83NO5 (801.6270907999999)

Cer 17:0;2O/16:5;(3OH)(FA 19:5)

C52H83NO5 (801.6270907999999)

Cer 15:0;2O/18:5;(3OH)(FA 19:5)

C52H83NO5 (801.6270907999999)

Lpc 38:1-SN1

C46H92NO7P (801.6611051999998)

4-[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-henicosanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-pentadecanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-heptadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(Z)-henicos-11-enoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

HexCer 22:1;3O/17:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 14:0;3O/25:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 26:1;3O/13:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 19:1;3O/20:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 18:1;3O/21:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 16:1;3O/23:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 21:1;3O/18:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 23:0;3O/16:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 20:1;3O/19:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 21:0;3O/18:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 17:1;3O/22:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 24:1;3O/15:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 25:1;3O/14:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 27:1;3O/12:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 26:0;3O/13:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 16:0;3O/23:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 17:0;3O/22:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 15:1;3O/24:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 23:1;3O/16:0;(2OH)

C45H87NO10 (801.6329642)

HexCer 15:0;3O/24:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 20:0;3O/19:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 24:0;3O/15:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 25:0;3O/14:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 19:0;3O/20:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 27:0;3O/12:1;(2OH)

C45H87NO10 (801.6329642)

HexCer 14:1;3O/25:0;(2OH)

C45H87NO10 (801.6329642)

[2-docosanoyloxy-3-[(Z)-hexadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-tetracosanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] tricosanoate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] pentacosanoate

C46H92NO7P (801.6611051999998)

[2-[(Z)-icos-11-enoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[2-[(Z)-tetracos-13-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] heptacosanoate

C46H92NO7P (801.6611051999998)

[2-icosanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

2-[hydroxy-[(E,2R,3S)-3-hydroxy-2-(tricosanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[3-[(E)-docos-11-enoyl]oxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(11E,14E)-pentacosa-11,14-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentacosanoylamino)hexadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-pentadecanoyloxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] henicosanoate

C46H92NO7P (801.6611051999998)

4-[3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-2-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-heptadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]henicosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(E)-docos-11-enoyl]oxy-3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(E)-icos-11-enoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(E)-icos-11-enoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-pentadecanoyloxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-henicosanoyloxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-henicosanoyloxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(E)-pentacos-11-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-hexadecanoyloxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tricosanoylamino)octadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-heptadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

[(2R)-3-[(E)-icos-1-enoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

4-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)docos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)henicos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)heptadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-icosanoyloxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-hexadecanoyloxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

[(2R)-2-icosanoyloxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

[(2R)-2-docosanoyloxy-3-[(E)-hexadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H92NO7P (801.6611051999998)

2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxyicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(E)-pentacos-11-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

4-[3-[(E)-pentadec-9-enoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-icosanoyloxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxypentadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] pentacosanoate

C46H92NO7P (801.6611051999998)

4-[2-[(E)-pentadec-9-enoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(11E,14E)-pentacosa-11,14-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] tricosanoate

C46H92NO7P (801.6611051999998)

4-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C49H87NO7 (801.6482191999999)

2-[[(E)-2-(heptadecanoylamino)-3-hydroxytetracos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]hexacosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(hexacosanoylamino)-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(octadecanoylamino)tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(hexadecanoylamino)-3-hydroxypentacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(icosanoylamino)henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(heptacosanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]henicosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(dodecanoylamino)-3-hydroxynonacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-heptacos-12-enoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-hexacos-11-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxynonacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(pentadecanoylamino)hexacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(tetradecanoylamino)heptacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(pentacosanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]tricosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(tetracosanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(docosanoylamino)-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]octacosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(tridecanoylamino)octacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]docosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(tricosanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxypentacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-docos-11-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(nonadecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(henicosanoylamino)-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]heptacosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-pentacos-11-enoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(decanoylamino)-3-hydroxyhentriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tricosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(nonacosanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxypentacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(heptanoylamino)-3-hydroxytetratriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(butanoylamino)-3-hydroxyheptatriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytetracosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(tritriacontanoylamino)oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(triacontanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-[[(Z)-docos-13-enoyl]amino]-3,4-dihydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H90N2O7P+ (801.6485299999999)

2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)dotriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)hexatriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(dotriacontanoylamino)-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(8E,12E)-2-(docosanoylamino)-3,4-dihydroxyoctadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H90N2O7P+ (801.6485299999999)

2-[[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3,4-dihydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C45H90N2O7P+ (801.6485299999999)

2-[hydroxy-[(E)-3-hydroxy-2-(octacosanoylamino)tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(hexanoylamino)-3-hydroxypentatriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octacosoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[(E)-2-(hentriacontanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-triacont-19-enoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)triacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[[2-[[(Z)-dotriacont-21-enoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)tritriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H94N2O6P+ (801.6849133999999)

1-(9Z-hexadecenyl)-2-docosanoyl-sn-glycero-3-phosphocholine

C46H92NO7P (801.6611051999998)

1-(1Z-hexadecenyl)-2-docosanoyl-glycero-3-phosphocholine

C46H92NO7P (801.6611051999998)

1-(9Z-octadecenyl)-2-eicosanoyl-sn-glycero-3-phosphocholine

C46H92NO7P (801.6611051999998)

phosphatidylcholine O-38:1

C46H92NO7P (801.6611051999998)

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 38 carbons and 1 double bond.

MePC(37:1)

C46H92NO7P (801.6611051999998)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(40:0)

C46H91NO9 (801.6693476)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

LPC(38:1)

C46H92NO7P (801.6611051999998)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 35:0;O2

C45H87NO10 (801.6329642)

DGTS 39:4

C49H87NO7 (801.6482191999999)

PC O-14:0/24:1

C46H92NO7P (801.6611051999998)

PC O-14:1/24:0

C46H92NO7P (801.6611051999998)

PC O-16:0/22:1

C46H92NO7P (801.6611051999998)

PC O-16:1/22:0

C46H92NO7P (801.6611051999998)

PC O-18:0/20:1

C46H92NO7P (801.6611051999998)

PC O-18:1/20:0

C46H92NO7P (801.6611051999998)

PC O-20:0/18:1

C46H92NO7P (801.6611051999998)

PC O-20:1/18:0

C46H92NO7P (801.6611051999998)

PC O-22:0/16:1

C46H92NO7P (801.6611051999998)

PC O-22:1/16:0

C46H92NO7P (801.6611051999998)

PC P-14:0/24:0

C46H92NO7P (801.6611051999998)

PC P-14:0/24:0 or PC O-14:1/24:0

C46H92NO7P (801.6611051999998)

PC P-16:0/22:0

C46H92NO7P (801.6611051999998)

PC P-16:0/22:0 or PC O-16:1/22:0

C46H92NO7P (801.6611051999998)

PC P-18:0/20:0

C46H92NO7P (801.6611051999998)

PC P-18:0/20:0 or PC O-18:1/20:0

C46H92NO7P (801.6611051999998)

PC P-20:0/18:0

C46H92NO7P (801.6611051999998)

PC P-20:0/18:0 or PC O-20:1/18:0

C46H92NO7P (801.6611051999998)

PC P-22:0/16:0

C46H92NO7P (801.6611051999998)

PC P-22:0/16:0 or PC O-22:1/16:0

C46H92NO7P (801.6611051999998)

PC P-38:0

C46H92NO7P (801.6611051999998)

PC P-38:0 or PC O-38:1

C46H92NO7P (801.6611051999998)

PE O-14:1/27:0

C46H92NO7P (801.6611051999998)

PE O-16:1/25:0

C46H92NO7P (801.6611051999998)

PE O-18:1/23:0

C46H92NO7P (801.6611051999998)

PE O-20:1/21:0

C46H92NO7P (801.6611051999998)

PE O-22:1/19:0

C46H92NO7P (801.6611051999998)

PE P-14:0/27:0

C46H92NO7P (801.6611051999998)

PE P-14:0/27:0 or PE O-14:1/27:0

C46H92NO7P (801.6611051999998)

PE P-16:0/25:0

C46H92NO7P (801.6611051999998)

PE P-16:0/25:0 or PE O-16:1/25:0

C46H92NO7P (801.6611051999998)

PE P-18:0/23:0

C46H92NO7P (801.6611051999998)

PE P-18:0/23:0 or PE O-18:1/23:0

C46H92NO7P (801.6611051999998)

PE P-20:0/21:0

C46H92NO7P (801.6611051999998)

PE P-20:0/21:0 or PE O-20:1/21:0

C46H92NO7P (801.6611051999998)

PE P-22:0/19:0

C46H92NO7P (801.6611051999998)

PE P-22:0/19:0 or PE O-22:1/19:0

C46H92NO7P (801.6611051999998)

PE P-41:0

C46H92NO7P (801.6611051999998)

PE P-41:0 or PE O-41:1

C46H92NO7P (801.6611051999998)

CerP 20:1;O2/26:0;O

C46H92NO7P (801.6611051999998)

CerP 21:1;O2/25:0;O

C46H92NO7P (801.6611051999998)

CerP 22:0;O2/24:1;O

C46H92NO7P (801.6611051999998)

CerP 22:1;O2/24:0;O

C46H92NO7P (801.6611051999998)

CerP 46:1;O2;O

C46H92NO7P (801.6611051999998)

GalCer 14:0;O2/26:0;O

C46H91NO9 (801.6693476)

GalCer 14:0;O3/26:0

C46H91NO9 (801.6693476)

GalCer 15:0;O2/25:0;O

C46H91NO9 (801.6693476)

GalCer 15:0;O3/25:0

C46H91NO9 (801.6693476)

GalCer 16:0;O2/24:0;O

C46H91NO9 (801.6693476)

GalCer 16:0;O3/24:0

C46H91NO9 (801.6693476)

GalCer 17:0;O2/23:0;O

C46H91NO9 (801.6693476)

GalCer 17:0;O3/23:0

C46H91NO9 (801.6693476)

GalCer 18:0;O2/22:0;O

C46H91NO9 (801.6693476)

GalCer 18:0;O3/22:0

C46H91NO9 (801.6693476)

GalCer 19:0;O2/21:0;O

C46H91NO9 (801.6693476)

GalCer 19:0;O3/21:0

C46H91NO9 (801.6693476)

GalCer 20:0;O2/20:0;O

C46H91NO9 (801.6693476)

GalCer 20:0;O3/20:0

C46H91NO9 (801.6693476)

GalCer 21:0;O2/19:0;O

C46H91NO9 (801.6693476)

GalCer 21:0;O3/19:0

C46H91NO9 (801.6693476)

GalCer 22:0;O2/18:0;O

C46H91NO9 (801.6693476)

GalCer 22:0;O3/18:0

C46H91NO9 (801.6693476)

GalCer 40:0;O2;O

C46H91NO9 (801.6693476)

GalCer 40:0;O3

C46H91NO9 (801.6693476)

GlcCer 14:0;O2/26:0;O

C46H91NO9 (801.6693476)

GlcCer 14:0;O3/26:0

C46H91NO9 (801.6693476)

GlcCer 15:0;O2/25:0;O

C46H91NO9 (801.6693476)

GlcCer 15:0;O3/25:0

C46H91NO9 (801.6693476)

GlcCer 16:0;O2/24:0;O

C46H91NO9 (801.6693476)

GlcCer 16:0;O3/24:0

C46H91NO9 (801.6693476)

GlcCer 17:0;O2/23:0;O

C46H91NO9 (801.6693476)

GlcCer 17:0;O3/23:0

C46H91NO9 (801.6693476)

GlcCer 18:0;O2/22:0;O

C46H91NO9 (801.6693476)

GlcCer 18:0;O3/22:0

C46H91NO9 (801.6693476)

GlcCer 19:0;O2/21:0;O

C46H91NO9 (801.6693476)

GlcCer 19:0;O3/21:0

C46H91NO9 (801.6693476)

GlcCer 20:0;O2/20:0;O

C46H91NO9 (801.6693476)

GlcCer 20:0;O3/20:0

C46H91NO9 (801.6693476)

GlcCer 21:0;O2/19:0;O

C46H91NO9 (801.6693476)

GlcCer 21:0;O3/19:0

C46H91NO9 (801.6693476)

GlcCer 22:0;O2/18:0;O

C46H91NO9 (801.6693476)

GlcCer 22:0;O3/18:0

C46H91NO9 (801.6693476)

GlcCer 40:0;O2;O

C46H91NO9 (801.6693476)

GlcCer 40:0;O3

C46H91NO9 (801.6693476)

HexCer 14:0;O2/26:0;2OH

C46H91NO9 (801.6693476)

HexCer 14:0;O2/26:0;3OH

C46H91NO9 (801.6693476)

HexCer 14:0;O2/26:0;O

C46H91NO9 (801.6693476)

HexCer 14:0;O3/26:0

C46H91NO9 (801.6693476)

HexCer 15:0;O2/25:0;2OH

C46H91NO9 (801.6693476)

HexCer 15:0;O2/25:0;3OH

C46H91NO9 (801.6693476)

HexCer 15:0;O2/25:0;O

C46H91NO9 (801.6693476)

HexCer 15:0;O3/25:0

C46H91NO9 (801.6693476)

HexCer 16:0;O2/24:0;2OH

C46H91NO9 (801.6693476)

HexCer 16:0;O2/24:0;3OH

C46H91NO9 (801.6693476)

HexCer 16:0;O2/24:0;O

C46H91NO9 (801.6693476)

HexCer 16:0;O3/24:0

C46H91NO9 (801.6693476)

HexCer 17:0;O2/23:0;2OH

C46H91NO9 (801.6693476)

HexCer 17:0;O2/23:0;3OH

C46H91NO9 (801.6693476)

HexCer 17:0;O2/23:0;O

C46H91NO9 (801.6693476)

HexCer 17:0;O3/23:0

C46H91NO9 (801.6693476)

HexCer 18:0;O2/22:0;2OH

C46H91NO9 (801.6693476)

HexCer 18:0;O2/22:0;3OH

C46H91NO9 (801.6693476)

HexCer 18:0;O2/22:0;O

C46H91NO9 (801.6693476)

HexCer 18:0;O3/22:0

C46H91NO9 (801.6693476)

HexCer 19:0;O2/21:0;2OH

C46H91NO9 (801.6693476)

HexCer 19:0;O2/21:0;3OH

C46H91NO9 (801.6693476)

HexCer 19:0;O2/21:0;O

C46H91NO9 (801.6693476)

HexCer 19:0;O3/21:0

C46H91NO9 (801.6693476)

HexCer 20:0;O2/20:0;2OH

C46H91NO9 (801.6693476)

HexCer 20:0;O2/20:0;3OH

C46H91NO9 (801.6693476)

HexCer 20:0;O2/20:0;O

C46H91NO9 (801.6693476)

HexCer 20:0;O3/20:0

C46H91NO9 (801.6693476)

HexCer 21:0;O2/19:0;2OH

C46H91NO9 (801.6693476)

HexCer 21:0;O2/19:0;3OH

C46H91NO9 (801.6693476)

HexCer 21:0;O2/19:0;O

C46H91NO9 (801.6693476)

HexCer 21:0;O3/19:0

C46H91NO9 (801.6693476)

HexCer 22:0;O2/18:0;2OH

C46H91NO9 (801.6693476)

HexCer 22:0;O2/18:0;3OH

C46H91NO9 (801.6693476)

HexCer 22:0;O2/18:0;O

C46H91NO9 (801.6693476)

HexCer 22:0;O3/18:0

C46H91NO9 (801.6693476)

HexCer 40:0;O2;O

C46H91NO9 (801.6693476)

HexCer 40:0;O3

C46H91NO9 (801.6693476)

GLCAE 26:5

C52H83NO5 (801.6270907999999)

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)tetracosanimidic acid

C46H91NO9 (801.6693476)